Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

GREY:VIVXF - Post Discussion

Avivagen Inc > Dr Jay is My Favourite VIV Basher!
View:
Post by Str8Shuter on Jan 30, 2020 1:08am

Dr Jay is My Favourite VIV Basher!

Ever since (s)he joined SH in April, 2018, it has been validation for me that VIV would be a good stock to accumulate shares of over time.  The more (s)he bashes, the more shares I want to buy!

Wonder what his/her salary is for bashing.  Must be pretty high, because the good Doctor seems to work very hard at what he/she does, pretty much every single day.  Jay repeatedly points out what a terribly managed company it is, with such terrible prospects for future success, but poor Jay always seems to find time in his/her busy day to say negatives about VIV instead of just moving on to greener pastures.  Hmmm... something doesn't quite add up.

Anyway, as a favour for the poor lass/lad, I guess I should place a bid for the Doctor to sell into, since they sound like they have their finger on the Sell button all day long just waiting for a buyer to take them out of their misery.  I just want to help.
Comment by DrJayser on Jan 30, 2020 11:26am
Glad Im helping your cause! safe to say you had plenny of time to accumulate this gem. Market cap remains constant, but the share price keeps on going down. you will be able to buy at 20 cents when the share count is at 100M. They will probably need another 12M$ in the next 36 months....thats another 50M shares right there. keep on buying and pay the ceo of a company that has less sales than ...more  
Comment by DrJayser on Feb 01, 2020 11:24am
Paid to bash a 20M$ mkt cap stock.....How dellusional can one be? to what purspose. its my perogative to denounce what I consider a public co. that I believe does not serve the interest of its shareholders. if you I rain on your delussional lttle parade , to bad so sad.  Fact remains, no profits loads of dilution , overpaid management.
Comment by DrJayser on Feb 18, 2020 7:50am
are you wondering what is Stoneman's salary for pumping this GEM? its much more plausible that AVIVAGEN pays pumpers as its always in need of Money!
Comment by DrJayser on Apr 09, 2020 9:45am
your strategy as really paid off! did you get any shares or warrants on the multiple rounds of equity dilution? are you a shareholder that voted for your wonderful and comitted CEO that receives 360,000$ a year in salary, holds no stocks and oversees the burn of 4M$ a year on average for a Company that  has approx. 1m$ in revenus per year. I welcome your comments! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities